Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin

BSE1938.35-1.05 (-0.05 %)

PREV CLOSE ( ) 1939.40

OPEN PRICE ( ) 1935.15

BID PRICE (QTY) 1936.85 (5)

OFFER PRICE (QTY) 1938.40 (6)

VOLUME 19442

TODAY'S LOW / HIGH ( )1935.15 1970.00

52 WK LOW / HIGH ( )1774 2403.45

NSE1936.70-2.5 (-0.13 %)

PREV CLOSE( ) 1939.20

OPEN PRICE ( ) 1941.90

BID PRICE (QTY) 1936.70 (18)

OFFER PRICE (QTY) 1937.00 (75)

VOLUME 171036

TODAY'S LOW / HIGH( ) 1934.70 1970.00

52 WK LOW / HIGH ( )1795.2 2402.9

Chairman	Manju D Gupta
Managing Director	Nilesh Gupta
Company Secretary	Amit Kumar Gupta
Executive Director	Ramesh Swaminathan
Non Executive Independent Director	K B S Anand Punita Kumar Sinha Mark D McDade Jeffrey Kindler Alfonso Zulueta Punita Lal

Incorporation Year : 01-03 1983

Registered Office :

Address : Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East) Mumbai,
Maharashtra-400055 .

Phone : 022 66402323

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE